The fraud estimate provided at yesterday's parliamentary inquiry reframes the debate. If billions of dollars are being lost to fraud, the argument for reform might shift from spending restraint to recovering funds diverted by criminality, but officials essentially admitted that the problem is too big to eliminate by prosecution.
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 Latest NewsBioPharmaOther Health
Latest Video
New Stories
-
The private market might do what two decades of PBS reform attempts couldn't
October 12, 2026 - - Latest News -
The full set of numbers tell the story and reveal the massive funding shortfall
October 12, 2026 - - Latest News -
Private prescription market heads towards $4 billion as PBS spending stalls
October 12, 2026 - - Latest News -
The 'Dispatched' Podcast Week in Review - Series 5. Ep.35
October 9, 2026 - - Podcast -
PhRMA goes to court over price rule that uses Australia as a benchmark
October 9, 2026 - - Latest News -
A tale of two systems with billions shifting to the private market
October 9, 2026 - - Latest News -
GLP-1s are quickly reshaping the Australian prescription medicines market
October 9, 2026 - - Latest News
